Washington, D.C., March 29 – Today, the National Coalition on Health Care (NCHC), the longest-running alliance of leading health care provider, purchaser, payer and consumer organizations, announced the retirement of its long-time President, John Rother, after many years of dedicated service to the organization, its members, and the national health care policy community.
NCHC & West Health Hill Briefing: The Burden of High Drug Prices Among Communities of Color
On March 18, from 1-2pm ET, The National Coalition on Health Care and West Health co-hosted the first of a two-part, Hill briefing series: “The Burden of High Drug Prices on Communities of Color”.
The Path Forward: The 2020 Elections and Re-Imagining the Health Care System Amid Crisis
On October 1, NCHC held a virtual event bringing together expert perspectives on the Trump and Biden presidential campaigns to share the candidates’ plan to reinvent our nation’s health care system for our patients, providers, and communities. The conversation was moderated by Noam Levey, a national health care reporter with the Los Angeles Times, followed by another […]
NCHC: Drug Pricing Primer
High prescription drug prices contribute to high total health care costs in the United States. Prices in the United States are higher than any other developed country, outpacing the effects of volume, types of drugs, or population size on total drug spending. Retail prescription drugs accounted for 9% of the $3.6 trillion (17.7% of GDP) […]
NCHC Statement on the Pricing of Remdesivir
On Monday, June 29, Gilead announced the pricing of remdesivir, an anti-viral drug that treats COVID-19. The Coalition supports protecting consumers from unaffordable drug costs. The pricing decision will exacerbate the health care affordability crisis already plaguing the country’s response to COVID-19. Fundamentally, the United States needs to develop a fair drug pricing system that […]
- 1
- 2
- 3
- …
- 9
- Next Page »